Ben Wylie

520 total citations
18 papers, 379 citations indexed

About

Ben Wylie is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Ben Wylie has authored 18 papers receiving a total of 379 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Immunology, 12 papers in Oncology and 4 papers in Molecular Biology. Recurrent topics in Ben Wylie's work include Immunotherapy and Immune Responses (13 papers), Cancer Immunotherapy and Biomarkers (8 papers) and Immune Cell Function and Interaction (6 papers). Ben Wylie is often cited by papers focused on Immunotherapy and Immune Responses (13 papers), Cancer Immunotherapy and Biomarkers (8 papers) and Immune Cell Function and Interaction (6 papers). Ben Wylie collaborates with scholars based in Australia, Germany and Cuba. Ben Wylie's co-authors include Jason Waithman, Christophe Macri, Justine D. Mintern, Weisan Chen, Bree Foley, Kun Xiao, Richard Lake, Damien Zanker, Lars Tögel and Bruce Robinson and has published in prestigious journals such as Nature Communications, PLoS ONE and Frontiers in Immunology.

In The Last Decade

Ben Wylie

18 papers receiving 374 citations

Peers

Ben Wylie
Ben Wylie
Citations per year, relative to Ben Wylie Ben Wylie (= 1×) peers Lindsay K. Ward-Kavanagh

Countries citing papers authored by Ben Wylie

Since Specialization
Citations

This map shows the geographic impact of Ben Wylie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ben Wylie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ben Wylie more than expected).

Fields of papers citing papers by Ben Wylie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ben Wylie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ben Wylie. The network helps show where Ben Wylie may publish in the future.

Co-authorship network of co-authors of Ben Wylie

This figure shows the co-authorship network connecting the top 25 collaborators of Ben Wylie. A scholar is included among the top collaborators of Ben Wylie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ben Wylie. Ben Wylie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Elaskalani, Omar, Ben Wylie, Caitlin M. Tilsed, et al.. (2024). Anti-metabolite chemotherapy increases LAG-3 expressing tumor-infiltrating lymphocytes which can be targeted by combination immune checkpoint blockade. Journal for ImmunoTherapy of Cancer. 12(9). e008568–e008568. 2 indexed citations
2.
Wang, Tao, et al.. (2024). Protocol for delivery of intraoperative immunotherapy to mice by surgical debulking of subcutaneous tumors. STAR Protocols. 5(2). 102948–102948. 1 indexed citations
3.
Wang, Tao, Omar Elaskalani, Marck Nörret, et al.. (2024). Local therapy with combination TLR agonists stimulates systemic anti-tumor immunity and sensitizes tumors to immune checkpoint blockade. OncoImmunology. 13(1). 2395067–2395067. 3 indexed citations
4.
Zemek, Rachael M., Wee Loong Chin, Vanessa S. Fear, et al.. (2022). Temporally restricted activation of IFNβ signaling underlies response to immune checkpoint therapy in mice. Nature Communications. 13(1). 4895–4895. 25 indexed citations
5.
Wylie, Ben, et al.. (2021). Targeting Cross-Presentation as a Route to Improve the Efficiency of Peptide-Based Cancer Vaccines. Cancers. 13(24). 6189–6189. 10 indexed citations
6.
Wagner, Teagan, Anthony Buzzai, Ben Wylie, et al.. (2021). IFNβ Is a Potent Adjuvant for Cancer Vaccination Strategies. Frontiers in Immunology. 12. 735133–735133. 18 indexed citations
7.
Buzzai, Anthony, Teagan Wagner, Lucy Barrett, et al.. (2020). Diverse Anti-Tumor Immune Potential Driven by Individual IFNα Subtypes. Frontiers in Immunology. 11. 542–542. 12 indexed citations
8.
Foley, Bree, Emma de Jong, Michelle Nguyen, et al.. (2020). Identifying the optimal donor for natural killer cell adoptive therapy to treat paediatric B‐ and T‐cell acute lymphoblastic leukaemia. Clinical & Translational Immunology. 9(7). e1151–e1151. 9 indexed citations
9.
Wylie, Ben, Anthony Buzzai, Teagan Wagner, et al.. (2019). CD8+XCR1neg Dendritic Cells Express High Levels of Toll-Like Receptor 5 and a Unique Complement of Endocytic Receptors. Frontiers in Immunology. 9. 2990–2990. 10 indexed citations
10.
Chee, Jonathan, Anthony Buzzai, Ben Wylie, et al.. (2019). Impaired T cell proliferation byex vivoBET-inhibition impedes adoptive immunotherapy in a murine melanoma model. Epigenetics. 15(1-2). 134–144. 6 indexed citations
11.
Wylie, Ben, Christophe Macri, Justine D. Mintern, & Jason Waithman. (2019). Dendritic Cells and Cancer: From Biology to Therapeutic Intervention. Cancers. 11(4). 521–521. 116 indexed citations
12.
Wylie, Ben, Jonathan Chee, Catherine A. Forbes, et al.. (2019). Acquired resistance during adoptive cell therapy by transcriptional silencing of immunogenic antigens. OncoImmunology. 8(8). 1609874–1609874. 15 indexed citations
13.
Wylie, Ben, Elke Seppanen, Kun Xiao, et al.. (2015). Cross-presentation of cutaneous melanoma antigen by migratory XCR1+CD103and XCR1+CD103+dendritic cells. OncoImmunology. 4(8). e1019198–e1019198. 30 indexed citations
14.
Fisher, Scott, Andrea Khong, Ben Wylie, et al.. (2014). Neoadjuvant anti-tumor vaccination prior to surgery enhances survival. Journal of Translational Medicine. 12(1). 245–245. 11 indexed citations
15.
Khong, Andrea, Ben Wylie, Scott Fisher, et al.. (2014). The efficacy of tumor debulking surgery is improved by adjuvant immunotherapy using imiquimod and anti-CD40. BMC Cancer. 14(1). 969–969. 20 indexed citations
16.
Waithman, Jason, Damien Zanker, Kun Xiao, et al.. (2013). Resident CD8+ and Migratory CD103+ Dendritic Cells Control CD8 T Cell Immunity during Acute Influenza Infection. PLoS ONE. 8(6). e66136–e66136. 52 indexed citations
17.
Wylie, Ben, Timothy Connor, C. Robinson, et al.. (2013). Long-term exposure of mesothelial cells to SV40 and asbestos leads to malignant transformation and chemotherapy resistance. Carcinogenesis. 35(2). 407–414. 16 indexed citations
18.
McDonnell, Alison M., Andrew Currie, Matthew D. Brown, et al.. (2012). Tumor cells, rather than dendritic cells, deliver antigen to the lymph node for cross-presentation. OncoImmunology. 1(6). 840–846. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026